Skip to main content

Petmed Express Inc (PETS)

Drugs Health Care
Stock AI

Financial Metrics

Price to Earnings-0.75x
Revenue Growth (1Y)-21.13%
Debt to Equity0.017x

Strengths

Stock Chart

Valuation

Petmed Express Inc is overvalued

News

All
Press Releases
News
Filings
PetMed Express, Inc. to Report First Quarter Fiscal Year 2027 Financial Results on Thursday, August 13, 2026
July 30, 2026PetMed Express, Inc. to Report First Quarter Fiscal Year 2027 Financial Results on Thursday, August 13, 2026
PetMeds Announces Proposed Sale-Leaseback of Headquarters and Distribution Center Buildings for $37 Million
July 23, 2026PetMeds Announces Proposed Sale-Leaseback of Headquarters and Distribution Center Buildings for $37 Million
PetMeds and Rural King Expand Access to Pet Healthcare Through New Online Pharmacy Platform
July 14, 2026PetMeds and Rural King Expand Access to Pet Healthcare Through New Online Pharmacy Platform
PetMed Express, Inc. Confirms Receipt of Unsolicited, Non-Binding, and Conditional Acquisition Proposal from SilverCape Investments Limited
June 30, 2026PetMed Express, Inc. Confirms Receipt of Unsolicited, Non-Binding, and Conditional Acquisition Proposal from SilverCape Investments Limited
PetMeds® Announces Fourth Quarter and Fiscal Year 2026 Financial Results
June 02, 2026PetMeds® Announces Fourth Quarter and Fiscal Year 2026 Financial Results
10-K Annual Report for 2026 FY
June 02, 202610-K Annual Report for 2026 FY
PetMed Express, Inc. to Report Fourth Quarter and Fiscal Year 2026 Financial Results on Tuesday, June 2, 2026
May 29, 2026PetMed Express, Inc. to Report Fourth Quarter and Fiscal Year 2026 Financial Results on Tuesday, June 2, 2026
PetMeds announces strategic partnership with Rural King to launch pet pharmacy offering across retail and digital channels
April 22, 2026PetMeds announces strategic partnership with Rural King to launch pet pharmacy offering across retail and digital channels
10-Q Quarterly Report for 2026 Q3
February 05, 202610-Q Quarterly Report for 2026 Q3
10-Q Quarterly Report for 2026 Q1
December 19, 202510-Q Quarterly Report for 2026 Q1
10-Q Quarterly Report for 2026 Q2
December 19, 202510-Q Quarterly Report for 2026 Q2
PetMed Express Comments on Unsolicited and Non-Binding Acquisition Proposal Received From SilverCape Investments Limited
December 11, 2025PetMed Express Comments on Unsolicited and Non-Binding Acquisition Proposal Received From SilverCape Investments Limited
PetMeds Announces Holiday Collection: Wellness-Focused Gifts for Pets and the People Who Love Them
December 10, 2025PetMeds Announces Holiday Collection: Wellness-Focused Gifts for Pets and the People Who Love Them
PetMeds Extends Existing Shareholder Rights Plan
November 26, 2025PetMeds Extends Existing Shareholder Rights Plan
PetMed Express, Inc. Announces Preliminary Second Quarter Results and Filing of Form 12b-25; Company Receives Expected Notice of Non-Compliance from Nasdaq
November 13, 2025PetMed Express, Inc. Announces Preliminary Second Quarter Results and Filing of Form 12b-25; Company Receives Expected Notice of Non-Compliance from Nasdaq
PetMed Express, Inc. Appoints Former Deloitte Partner James LaCamp as Director and Audit Committee Chair
October 20, 2025PetMed Express, Inc. Appoints Former Deloitte Partner James LaCamp as Director and Audit Committee Chair
PetMeds® Files Form 10-K for Fiscal 2025
October 14, 2025PetMeds® Files Form 10-K for Fiscal 2025
10-K Annual Report for 2025 FY
October 14, 202510-K Annual Report for 2025 FY
PetMed Express, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
October 08, 2025PetMed Express, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
PetMed Express, Inc. Announces Management Changes
August 12, 2025PetMed Express, Inc. Announces Management Changes
PetMeds Partners with myBalto Foundation to Raise Nearly $45,000 to Alleviate Financial Stress Pet Owners Face with Emergency Vet Bills
July 23, 2025PetMeds Partners with myBalto Foundation to Raise Nearly $45,000 to Alleviate Financial Stress Pet Owners Face with Emergency Vet Bills
PetMed Express Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Annual Report on Form 10-K
July 03, 2025PetMed Express Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Annual Report on Form 10-K
PetMed Express, Inc. Provides Update on Status of Fourth Quarter and FY 2025 Results and Form 10-K Filing
July 01, 2025PetMed Express, Inc. Provides Update on Status of Fourth Quarter and FY 2025 Results and Form 10-K Filing
Securities Fraud Investigation Into PetMed Express, Inc. (PETS) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
June 26, 2025Securities Fraud Investigation Into PetMed Express, Inc. (PETS) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
PetMed Express, Inc. (PETS) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
June 25, 2025PetMed Express, Inc. (PETS) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
Securities Fraud Investigation Into PetMed Express, Inc. (PETS) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
June 24, 2025Securities Fraud Investigation Into PetMed Express, Inc. (PETS) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
Wagmo Partners with PetMeds® to Bring Everyday Pet Health Savings to Members
June 24, 2025Wagmo Partners with PetMeds® to Bring Everyday Pet Health Savings to Members
PetMed Express, Inc. Announces Preliminary Fourth Quarter and FY 2025 Results and Filing of Form 12b-25
June 16, 2025PetMed Express, Inc. Announces Preliminary Fourth Quarter and FY 2025 Results and Filing of Form 12b-25
PetMed Express, Inc. Announces Delay in Fourth Quarter and Fiscal Year End Earnings Release and Conference Call
June 10, 2025PetMed Express, Inc. Announces Delay in Fourth Quarter and Fiscal Year End Earnings Release and Conference Call
PetMed Express, Inc. Sets Fourth Quarter and Full Fiscal Year 2025 Earnings Call
May 27, 2025PetMed Express, Inc. Sets Fourth Quarter and Full Fiscal Year 2025 Earnings Call
PetMed Express, Inc. and Dutch Announce Partnership to Provide Accessible Telehealth Services for Pets
May 07, 2025PetMed Express, Inc. and Dutch Announce Partnership to Provide Accessible Telehealth Services for Pets
PetMeds® to Ring Nasdaq Opening Bell in Celebration of National Pet Day on April 11th
April 11, 2025PetMeds® to Ring Nasdaq Opening Bell in Celebration of National Pet Day on April 11th
PetMed Express, Inc. Announces Appointment of Peter Batushansky to Board of Directors
April 09, 2025PetMed Express, Inc. Announces Appointment of Peter Batushansky to Board of Directors
PetMeds® Announces Third Quarter Fiscal 2025 Financial Results
February 10, 2025PetMeds® Announces Third Quarter Fiscal 2025 Financial Results
10-Q Quarterly Report for 2025 Q3
February 10, 202510-Q Quarterly Report for 2025 Q3
PetMed Express, Inc. Sets Fiscal Third Quarter 2025 Earnings Call
January 30, 2025PetMed Express, Inc. Sets Fiscal Third Quarter 2025 Earnings Call
10-Q Quarterly Report for 2025 Q2
November 07, 202410-Q Quarterly Report for 2025 Q2
10-Q Quarterly Report for 2025 Q1
August 07, 202410-Q Quarterly Report for 2025 Q1
10-K Annual Report for 2024 FY
June 14, 202410-K Annual Report for 2024 FY
10-K/A Annual Report for 2023 FY
April 15, 202410-K/A Annual Report for 2023 FY
10-Q/A Quarterly Report for 2024 Q1
April 15, 202410-Q/A Quarterly Report for 2024 Q1
10-Q/A Quarterly Report for 2024 Q2
April 15, 202410-Q/A Quarterly Report for 2024 Q2
10-Q Quarterly Report for 2024 Q3
April 15, 202410-Q Quarterly Report for 2024 Q3
10-Q Quarterly Report for 2024 Q2
October 31, 202310-Q Quarterly Report for 2024 Q2
10-Q Quarterly Report for 2024 Q1
August 02, 202310-Q Quarterly Report for 2024 Q1
10-K Annual Report for 2023 FY
May 23, 202310-K Annual Report for 2023 FY
10-Q Quarterly Report for 2023 Q3
February 07, 202310-Q Quarterly Report for 2023 Q3
10-Q Quarterly Report for 2023 Q2
November 08, 202210-Q Quarterly Report for 2023 Q2
10-Q Quarterly Report for 2023 Q1
August 02, 202210-Q Quarterly Report for 2023 Q1
10-K Annual Report for 2022 FY
May 24, 202210-K Annual Report for 2022 FY
10-Q Quarterly Report for 2022 Q3
February 04, 202210-Q Quarterly Report for 2022 Q3
10-Q Quarterly Report for 2022 Q2
November 02, 202110-Q Quarterly Report for 2022 Q2

A. Company Overview

PetMed Express Inc., commonly referred to as PetMeds, is a prominent player in the direct-to-consumer pet pharmacy sector. Established in 1996, the company has built a strong reputation for providing a wide selection of pet medications and wellness products to pet owners across North America. It operates alongside PetCareRx, a subsidiary acquired in April 2023, further enhancing its offerings in the pet healthcare space. The primary objective is to empower pet families with the means to care for their dogs, cats, and horses, delivering products that support both preventive and chronic health needs.

The company's operations are anchored on its commitment to quality and customer service. PetMeds represents both brands through its digital platforms, primarily via websites and toll-free numbers, allowing easy access for customers. The company serves a substantial and growing customer base, boasting over two million purchasers in the past three fiscal years.

B. Business Operations

Industry Focus

PetMed Express Inc. focuses specifically on the pet wellness segment for dogs, cats, and horses. The product assortment includes prescription medications, over-the-counter (OTC) medications, dietary supplements, specialized pet foods, and an extensive range of pet supplies. The total addressable market for pet medications and related health products continues to expand, driven by a significant increase in overall pet spending, which reached $147 billion in 2023. This includes approximately $38 billion spent on veterinary care and prescription medications, highlighting a continuous demand for pet health products.

Customer Demographics

The company's customer base is diverse and widespread across the United States. Key markets include large populations in states such as California, Florida, Texas, New York, Pennsylvania, North Carolina, Georgia, and Virginia. A significant percentage of customers demonstrate loyalty to the brands through repeated purchases, with an average order value slightly increasing year over year.

PetMed Express places great emphasis on customer engagement and satisfaction. The company’s pet health specialists support over 100,000 inquiries each month, demonstrating its commitment to providing personalized assistance. This includes a range of contact options, such as telephone, chat, and email support.

C. Products and Services

PetMeds offers a comprehensive selection of more than 15,000 stock-keeping units (SKUs) of products catering to different pet health needs. The offerings include:

Prescription Medications

  • Heartworm and flea/tick preventatives
  • Specialty medications for conditions such as arthritis, dermatitis, diabetes, and more

Non-Prescription Medications and Supplies

  • Vitamins, nutritional supplements, and over-the-counter treatments for fleas and ticks
  • Hygiene and household pet supplies

Pet Foods

  • A range of both premium and non-premium pet foods, including veterinary prescription diets.

Private Label Products

  • A line of exclusive private label items that deliver value-for-money options for pet care.

Holistic Wellness Services

  • Telemedicine through its VetLive service, which allows virtual consultations with licensed veterinarians.
  • Pet insurance options through strategic partnerships, offering coverage for health and wellness needs.

Veterinary Advisory Board

To ensure professional and educational excellence, the company has established a Veterinary Advisory Board comprising experienced veterinarians who contribute expert insight and guidance for the company's initiatives.

D. Strategic Developments and Partnerships

Recent acquisitions and partnerships have enhanced the company's product offerings and market presence. The acquisition of PetCareRx expanded the customer base and product catalog significantly. The partnership with Pumpkin Insurance allows PetMeds to offer pet insurance options, further integrating pet health solutions under one platform. A collaboration with Vetster provides telehealth services, ensuring that pet owners have seamless access to veterinary care.

E. Marketing and Customer Engagement Strategy

PetMed's marketing strategies focus on enhancing brand recognition and increasing customer loyalty. This approach includes:

  • A multi-channel marketing strategy incorporating digital and traditional media to reach different customer segments.
  • Development of content that communicates the company’s dedication to pet health and wellness.
  • A tiered pricing strategy that accommodates various budgets, ensuring affordability and accessibility for diverse consumers.

F. Distribution Channels

The company utilizes several distribution channels to reach customers effectively. The primary sales avenues include:

  • Internet Sales: Engaging customers through its websites, facilitating user-friendly online shopping experiences.
  • Call Center Support: A dedicated customer service center that assists customers with purchasing decisions and inquiries, ensuring a high-touch approach.
  • Partnership Networks: Collaborations with brokers and networks to provide pet care benefits through employers.

G. Operational Infrastructure

PetMeds operates with a robust operational infrastructure that includes state-accredited pharmacies staffed by licensed pharmacists specialized in veterinary medicine. The organization follows a strict 5-point verification process to ensure medication safety and compliance with federal and state regulations.

Inventory management relies on strategic partnerships with key suppliers, forming a diverse sourcing strategy that secures a steady supply of products. The company is committed to ongoing investment in technology to streamline operations and improve customer experience across its platforms.

H. Competitive Landscape

PetMed Express Inc. operates in a competitive environment, contending with other e-commerce pet supply retailers, veterinary services, and traditional pet store chains. The company differentiates itself through its focus on quality assurance, customer service, and specialized veterinary expertise, allowing it to maintain a strong presence in the marketplace.

Engaging actively in maintaining compliance with evolving regulatory landscapes and promoting intellectual property through its brand trademarks further cements its position as a trusted resource in the pet wellness industry.

Stock Infos

SectorHealth Care
IndustryDrugs
CEOMathew N. Hulett

Dividends

Copyright ©2026 Taurigo GmbH. All rights reserved.Taurigo GmbH provides no investment advice. Any analyses, research, ideas, prices, or other information contained on this website are provided as general market information for educational and entertainment purposes only, and do not constitute investment advice. We assume no responsibility for the accuracy, completeness or timeliness of any financial information contained on this site. In particular, we do not constitute an invitation to buy, sell or hold securities or other financial products. We shall not be liable for any loss or damage, including without limitation loss of profits, arising directly or indirectly from use of or reliance on the provided information. Before making any investment decision, you should consider whether it is suitable for your situation and obtain appropriate financial, tax and legal advice.